Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.

Dementia and geriatric cognitive disorders - 1 Jan 2020

Toft Anders, Roos Peter, Jääskeläinen Olli, Musaeus Christian Sandøe, Henriksen Emil Elbæk, Johannsen Peter, Nielsen Troels Tolstrup, Herukka Sanna-Kaisa, Hviid Simonsen Anja, Nielsen Jørgen Erik

Abstract excerpt

INTRODUCTION: The potential of neurofilament light (NfL) as a blood-based biomarker is currently being investigated in autosomal dominant neurodegenerative disease. This study explores the clinical utility of serum-NfL in frontotemporal dementia due to CHMP2B mutation (FTD-3). METHODS: This cross-sectional study included serum and CSF data from 38 members of the Danish FTD-3 family: 12 affected CHMP2B mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Endosomal Sorting Complexes Required for Transport

Share to Frontotemporal Dementia

Share to Intermediate Filaments

Share to Mutation

Share to Neurofilament Proteins

Source

Identifiers

PMID: 33626531
DOI: 10.1159/000513877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.PMID 33626531Read ↗

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers.Semantic proximity Read ↗

Neurofilament light chain: a biomarker for genetic frontotemporal dementiaSemantic proximity Read ↗

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s diseaseSemantic proximity Read ↗

Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersSemantic proximity Read ↗

Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia SyndromesSemantic proximity Read ↗

Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapiesSemantic proximity Read ↗

Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disordersSemantic proximity Read ↗

Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disordersSemantic proximity Read ↗

Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.Semantic proximity Read ↗

Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review.Semantic proximity Read ↗

NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study.Semantic proximity Read ↗

Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.